Antiandrogens. 2',3' -Tetrahydrofuran-2'spiro-17-(1,2 -methylene-4-androsten-3-ones).
D000726:Androgen Antagonists; D000736:Androstenes / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002369:Castration; D005663:Furans / Q000138:chemical synthesis* / Q000494:pharmacology; D007664:Ketosteroids / Q000138:chemical synthesis / Q000494:pharmacology; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009904:Optical Rotation; D009929:Organ Size; D011467:Prostate / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D012669:Seminal Vesicles / Q000187:drug effects; D013056:Spectrophotometry, Ultraviolet; D013141:Spiro Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D013329:Structure-Activity Relationship
D000726:Androgen Antagonists; D000736:Androstenes; D005663:Furans; D007664:Ketosteroids; D013141:Spiro Compounds